The electrical stimulation of bovine cerebral arteries preincubated wi
th [H-3]-noradrenaline (NA) evoked tritium overflow, which was reduced
by tetrodotoxin, Ca2+-free medium and denervation by pretreatment wit
h 6-hydroxydopamine. 2 The evoked tritium overflow was reduced by non-
selective, 5-hydroxytryptamine (5-HT), and selective, 5-carboxamidotry
ptamine (5-CT) and sumatriptan, agonists of 5-HT1-like receptors, the
latter with certain preference for the 5-HT1D subtype. This overflow w
as also reduced by NA and B-HT 920 (non-selective and selective agonis
ts of alpha2-adrenoceptors), enhanced by metitepine (antagonist of 5HT
1 and 5-HT2 receptors), and unaltered by ketanserin (antagonist of 5-H
T2 receptors), methysergide (antagonist of 5-HT1 and 5-HT2 receptors)
and phentolamine (antagonist of alpha- and 5-HT1 receptors). The metit
epine increase was blocked by cocaine and phentolamine. 3 The release-
inhibiting effect of 5-HT was reduced by cocaine, metitepine, phentola
mine and methysergide, but not by ketanserin. Metitepine reversed the
inhibition caused by 5-CT and sumatriptan. Metitepine, methysergide an
d phentolamine antagonized the inhibition of the tritium overflow elic
ited by B-HT 920. 4 These results suggest: (1) the evoked NA release i
s modulated by 5-HT1-like receptors, likely to be of 5-HT1D subtype; a
nd (2) metitepine has also the ability to block NA uptake and to antag
onize presynaptic a2-adrenoceptors.